ITGB2 and asthma: In healthy subjects, reduced CD54 and CD18 on monocytes; decreased CD18 and CD49d on granulocytes; decreased CD25 in blood monocytes, basophils, and eosinophils; increased lymphocyte expression of CD25.In asthma, reduced CD11b on monocytes and eosinophils, CD54 on granulocytes, the percentage of CD4+ T cells, basophils, and eosinophils